Recruiting
Whole Body HER3 Quantification With Radiolabelled Patritumab Deruxtecan (HER3-DXd) PET/CT
NCT06222489
- Conditions
- Advanced Non-Small Cell Squamous Lung Cancer, Bronchial Neoplasms, Carcinoma, Bronchogenic, +10 more
- Locations
-
- Antoni van Leeuwenhoek Amsterdam, North Holland, Netherlands